<DOC>
	<DOCNO>NCT02946762</DOCNO>
	<brief_summary>At correctional facility Zambia South Africa , cross-sectional study design use characterize full continuum integrate HIV/TB care Treatment Prevention ( TasP ) , enrich approach : 1 ) use individual-level cohort data HIV-infected inmate assess ART uptake TasP/Universal Test Treat ( UTT ) , well 6-month virological suppression retention care inmates initiate ART ; 2 ) mixed method identify health-system , corrections-related socio-cultural individual-inmate barrier facilitator TasP/UTT refine TasP implementation ; 3 ) conduct retrospective chart review use routine data Ministry Health register reconstruct approximate HIV TB cascade inmate ( HIV-infected HIV-uninfected ) 3 12 month TasP/UTT implementation .</brief_summary>
	<brief_title>TasP Correctional Facilities</brief_title>
	<detailed_description>Treatment Prevention ( TasP ) offer promise : ( 1 ) prevent HIV transmission among incarcerated population ; ( 2 ) improve inmate health tuberculosis control provision immediate ART use `` universal test treat '' ( UTT ) approach . Increased uptake routine HIV counsel test ( HCT ) service encourage currently available ART care augment offer immediate ART initiation HIV-infected inmate already ART ( screen TB kidney disease ) regardless CD4 count . In way , study promote universal HCT ART access . Existing , routine service delivery platform operate MOH Zambia Corrections Service strengthen hope achieve follow : 1 . Universal HIV test within 2 month facility entry annually current inmate 2 . Clear integration TB screening treatment within HIV care service 3 . Scaling-up inmate peer supporter support group promote ART adherence 4 . Strengthened system provide integrated TB/HIV care correctional setting 5 . Improved continuity care prisoner initiate ART The following study-specific procedure carry : - ART initiate follow clinical laboratory assessment accord local guideline . - All inmates newly diagnose previously document HIV infection offer immediate ART regardless CD4+ count WHO clinical stage . A clinical assessment , include TB screening , test serum creatinine complete , per Zambian national guideline , prior start standard ART regimen , Zambia efavirenz plus lamivudine/ emtricitabine tenofovir . - A study specific follow-up visit , align routine HIV care schedule , inmates identify HIV-infected occur : - Study nurse support blood sample collection HIV-1 viral load monitoring single study follow-up visit participant initiate ART TasP . The planned follow-up visit schedule occur 6 month follow ART initiation . However , high recidivism rate loss follow-up prior 6 month treatment observe , study follow-up visit may move 3 month . Study data collection augment exist routine data collection mechanism allow individual-level outcome ascertainment regard uptake ART TasP , well 6-month retention care virological suppression . Standardized questionnaire in-depth interview conduct inmate participant enrol Objective 1 . To assess systems-level issue , in-depth interview also conduct purposive sample correctional staff health care worker .</detailed_description>
	<mesh_term>Tuberculosis</mesh_term>
	<criteria>Previously know newly diagnose HIVinfected inmates Not ART No document release date within 30 day enrollment Incarcerated adult correctional ward one three study site .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>HIV</keyword>
	<keyword>TB</keyword>
	<keyword>Antiretroviral Treatment</keyword>
	<keyword>Anti-tuberculosis Treatment</keyword>
	<keyword>HIV Counselling Testing</keyword>
	<keyword>Treatment Prevention</keyword>
</DOC>